On this page you can find the key documents for all IML funds.  Please contact us if you can’t find what you’re looking for.

Product disclosure documents

Please note the Investment Guide forms part of the Product Disclosure Statement (PDS) for all Funds excluding the Investors Mutual Private Portfolio Fund and the Concentrated Australian Share Fund (Active ETF).

Target market determinations

Forms

Webinar series | Quality over chaos: navigating today’s sharemarket
Featuring the IML Investment Team
Australian and global markets have been very buoyant over the course of 202...
Find out more
Head and shoulders shot of Jason Guthrie and Marc Whittaker
Small-mid cap portfolio update – March quarter 2025
Featuring Marc Whittaker.
IML Portfolio Manager, Marc Whittaker, talks how IML’s small and mid cap ...
Find out more
Is momentum shifting back to fundamentals?
Featuring Daniel Moore and Michael O'Neill
Portfolio managers Daniel Moore and Michael O'Neill provide an update on th...
Find out more
Is this ASX healthcare stock ready to rocket post-merger?
Featuring Marc Whittaker
This ASX healthcare stock is now Australia’s 2nd largest radiology provid...
Find out more

INVESTMENT INSIGHTS & PERFORMANCE UPDATES

Subscribe to receive IML’s regular performance updates, invitations to webinars as well as regular insights from IML’s investment team, featured in the Natixis Investment Managers Expert Collective newsletter.

IML marketing in Australia is distributed by Natixis Investment Managers, a related entity. Your subscriber details are being collected by Natixis Investment Managers Australia, on behalf of IML. Please refer to our Privacy Policy. Natixis Investment Managers Australia Pty Limited (ABN 60 088 786 289) (AFSL No. 246830) is authorised to provide financial services to wholesale clients and to provide only general financial product advice to retail clients.